Work

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients

Year: 1998

Type: article

Study design: Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(98)00211-1

Authors: Y Sakata, A Ohtsu, N Horikoshi, K Sugimachi, Y Mitachi, T Taguchi

Institutions: Aomori Prefectural Central Hospital, National Cancer Center Hospital East, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Kyushu University, Kyushu University Hospital, Sendai Kousei Hospital

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2018619890

FWCI: 11.01

Cites: 29

Cited by: 565

Related to: 10